Kumar Gaurav
 "Kumar Gaurav")
Kumar Gaurav
Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.
Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.
Page 3 - Kumar Gaurav
Tejas fighter jet mishap doesn't shake HAL's long-term prospects: Choice
While export sentiment may see a temporary setback, brokerage believes the near- to medium-term focus remains firmly on domestic deliveries, particularly the production ramp-up of the Tejas Mk-1A
 "Tejas fighter jet mishap doesn't shake HAL's long-term prospects: Choice")
Groww snaps two-day loss; will it follow Ola Electric's rollercoaster path?
Despite the rebound, the stock remains around 13 per cent below its November 18 peak of ₹193.80, achieved less than a week after listing
 "Groww snaps two-day loss; will it follow Ola Electric's rollercoaster path?")
Crypto market losses mount, yet analysts warn against panic; here's why
Crypto Market Crash: Analysts say the pullback reflects a consolidation phase rather than market capitulation, as participants digest recent selling pressure and await clearer macroeconomic signals
 "Crypto market losses mount, yet analysts warn against panic; here's why")
PVC price pressure dents earnings; Nuvama says 'Hold' Astral, Supreme Ind
A sharper-than-expected decline in PVC prices following the lack of anti-dumping duty (ADD) and the withdrawal of BIS norms has further worsened the operating environment
 "PVC price pressure dents earnings; Nuvama says 'Hold' Astral, Supreme Ind")
Stocks to Watch today, Nov 21: RIL, TCS, Hyundai Motor, Adani Ports, Nestle
Stocks to Watch Today, November 21, 2025: Nestle India, Adani Ports, 360 ONE WAM, Alkem Laboratories, JSW Energy, and Zaggle Prepaid are among the top stocks to remain in focus today
 "Stocks to Watch today, Nov 21: RIL, TCS, Hyundai Motor, Adani Ports, Nestle")
Stocks to Watch today, Nov 18: PhysicsWallah, BSE, HCL Tech, Infosys, Paytm
Stocks to Watch Today, November 18, 2025: Tata Power Company, TVS Motor Company, Emcure Pharma, AstraZeneca Pharma, JSW Energy, JSW Cement, and WPIL are among the top stocks to remain in spotlight
Nuvama retains 'Buy' on Eureka Forbes post Q2, sees 28% upside; here's why
Nuvama has retained its 'Buy' tag on the stock, revising the target price to ₹750 per share from ₹700 per share, following a 32 per cent year-on-year jump in PAT to ₹61.6 crore in Q2FY26
 "Nuvama retains 'Buy' on Eureka Forbes post Q2, sees 28% upside; here's why")
Stocks to Watch today, Nov 17: Maruti Suzuki, Ola Electric, Marico, Lupin
Stocks to Watch Today, November 17, 2025: Marico, Glenmark Pharma, FirstCry, Siemens, Dish TV, Alembic Pharma, Cyient, and Websol Energy System are among the top stocks to remain in focus today
 "Stocks to Watch today, Nov 17: Maruti Suzuki, Ola Electric, Marico, Lupin")
Who's in control of India Inc? Mutual Funds thrive as FPIs face 15-yr slump
Domestic mutual funds extended their record-breaking run, with ownership climbing to an all-time high of 10.9 per cent (Active: 9.0 per cent, Passive: 1.0 per cent).
 "Who's in control of India Inc? Mutual Funds thrive as FPIs face 15-yr slump")
Biocon scales biosimilars, cuts debt; analysts bullish post Q2 results
MOFSL and JM Financial retained their Buy ratings, while Nuvama upgraded Biocon to Buy from Hold after the company posted a net profit of ₹85 crore in Q2FY26
 "Biocon scales biosimilars, cuts debt; analysts bullish post Q2 results")
Ashok Leyland at crossroads after Q2: Buy for growth or reduce for caution?
While Choice has reiterated its Buy rating, citing resilient operational performance & steady market leadership, Nuvama has maintained 'Reduce' on valuation concerns and moderation in industry growth
 "Ashok Leyland at crossroads after Q2: Buy for growth or reduce for caution?")
Supriya Life up 3% as Choice initiates with 'Buy' on strong margin strength
Analysts believe the company is well-positioned for "sustained, high-quality growth," reinforcing long-term earnings visibility
 "Supriya Life up 3% as Choice initiates with 'Buy' on strong margin strength")
Will investors' money grow with Groww IPO listing? Here's what GMP hints at
Groww IPO Listing: Shares of Groww are set to make their D-Street debut tomorrow, November 12, 2025. Here's what the latest grey market premium (GMP) hints at regarding the tentative listing
 "Will investors' money grow with Groww IPO listing? Here's what GMP hints at")
Tata Motors demerger: CV shares entitlement, swap ratio, listing timeline
Once listed, the CV stock will debut under a separate ticker, allowing independent trading of the two Tata Motors companies
 "Tata Motors demerger: CV shares entitlement, swap ratio, listing timeline")
Q2 premium, margin growth boost analysts' bullish outlook on LIC stock
Emkay Global Financial Services has retained its 'Add' rating on the insurance behemoth, while Motilal Oswal Financial Services (MOFSL) has maintained its 'Buy' recommendation
 "Q2 premium, margin growth boost analysts' bullish outlook on LIC stock")
Q2FY26 results in line; Aurobindo Pharma could gain 25%, says Nuvama
According to Nuvama, Aurobindo's Q2FY26 revenue and Ebitda were ahead of consensus estimates by 2 per cent and 1 per cent, respectively, though PAT missed expectations by about 5 per cent
 "Q2FY26 results in line; Aurobindo Pharma could gain 25%, says Nuvama")
MFs near parity with FIIs as ownership gap hits record low: Prime Database
The share of FIIs declined further to a 13-year low of 16.71 per cent as on September 30, 2025 (down from 17.05 per cent on June 30, 2025), while MF holdings rose to an all-time high of 10.93 per cent
 "MFs near parity with FIIs as ownership gap hits record low: Prime Database")
Motilal Oswal gives 'Buy' to Waaree Energies, calls it a sector bellwether
With operational cell/module capacity of 5.4 GW/16.1 GW in India, WEL, analysts believe, towers domestic competitors and enjoys a formidable India capacity market share of 21.6 per cent/13.3 per cent
 "Motilal Oswal gives 'Buy' to Waaree Energies, calls it a sector bellwether")
Lenskart IPO allotment likely today; here's how to check status, latest GMP
Once the allotment is finalised, applicants can verify their allotment status online through the official websites of the BSE, NSE, or MUFG Intime India, the registrar to the issue
 "Lenskart IPO allotment likely today; here's how to check status, latest GMP")
Groww IPO: Justified valuation or time to chase better-valued rivals?
While Groww IPO attracts moderate interest, analysts debate if listed peers offer better value for money
 "Groww IPO: Justified valuation or time to chase better-valued rivals?")
